在胰腺癌中的外周,中心和化疗诱导的神经病变
Luju Jiang1, Shuqi Cai1, Zheqi Weng1
1State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, PR China.
Trends in neurosciences
|December 27, 2024
概括
胰腺癌显著改变神经系统,影响开始和进展. 针对这种神经癌症交叉通话,为治疗和疼痛管理提供了新的途径.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
背景情况:
- 胰腺癌涉及到外周和中枢神经系统 (CNS) 的显著变化.
- 这些神经变化包括轴突发生,神经重塑,围神经入侵和围神经神经炎.
- 癌症缓解症和化疗也可以诱导胰腺癌患者的神经病变.
研究的目的:
- 总结最近关于胰腺癌神经病变分子机制的发现.
- 讨论在胰腺癌中针对神经系统的潜在干预策略.
- 突出神经改变对癌症发病,进展和患者生活质量的影响.
主要方法:
- 关于胰腺癌和神经系统的最新科学文献的综述.
- 对神经病变背后的分子机制的分析.
- 讨论针对神经与癌症相互作用的治疗策略.
主要成果:
- 胰腺癌引发了显著的外周和中枢神经系统的改变.
- 这些神经病变影响癌症的发病,进展和缓解症.
- 化疗相关的神经病变是一种常见的并发症,导致神经损伤和认知问题.
结论:
- 针对胰腺癌与神经系统之间的交叉通讯提供了有前途的治疗机会.
- 干预措施可以提高癌症治疗效率,缓解疼痛,提高患者的生活质量.
- 对分子机制的进一步研究对于开发有效策略至关重要.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
Chronic Pancreatitis I: Introduction
71
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
71
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
222
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
222
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
174
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
174
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
201
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
201
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70


